Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.

The Journal of antimicrobial chemotherapy - 1 Nov 2010

Oteo Jesús, Bautista Verónica, Lara Noelia, Cuevas Oscar, Arroyo Margarita, Fernández Sara, Lázaro Edurne, de Abajo Francisco J, Campos José

Abstract excerpt

OBJECTIVES: To document fosfomycin susceptibility of extended-spectrum β-lactamase-producing Escherichia coli (ESBL-EC), analyse trends in fosfomycin use and investigate fosfomycin resistance in ESBL-EC isolated from urinary tract infections (UTIs). METHODS: Twenty-seven Spanish hospitals partici...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Typing Techniques
Share to beta-Lactamases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Fingerprinting

Share to Escherichia coli Infections

Share to Fosfomycin

Share to Serotyping

Share to Urinary Tract Infections

Source

Identifiers

PMID: 20851815
DOI: 10.1093/jac/dkq346

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20851815-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli.PMID 20851815Read ↗

CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.Semantic proximity Read ↗

Plasmid-mediated fosfomycin resistance in Escherichia coli isolates of worldwide originSemantic proximity Read ↗

Extended-spectrum β-lactamase-producing Enterobacteriaceae: in vitro susceptibility to fosfomycin, nitrofurantoin and tigecycline.Semantic proximity Read ↗

Occurrence of multidrug resistance to oral antibiotics among Escherichia coli urine isolates from outpatient departments in Germany: extended-spectrum β-lactamases and the role of fosfomycin.Semantic proximity Read ↗

Evaluation of Fosfomycin Activity Against Extended Spectrum Beta Lactamase (ESBL) Producing Enterobacteriaceae Isolated from Three Centers of Tehran, Iran.Semantic proximity Read ↗

Emergence of Fosfomycin Resistance by Plasmid-Mediated fos Genes in Uropathogenic ESBL-Producing E. coli Isolates in MexicoSemantic proximity Read ↗

Characterisation of fosfomycin resistance mechanisms and molecular epidemiology in extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates.Semantic proximity Read ↗

Escherichia coli resistant to fosfomycin from urinary tract infections: Detection of the fosA3 gene in SpainSemantic proximity Read ↗

Mobile fosfomycin resistance genes in Enterobacteriaceae—An increasing threatSemantic proximity Read ↗

Fosfomycin: evaluation of the published evidence on the emergence of antimicrobial resistance in Gram-negative pathogens.Semantic proximity Read ↗

Occurrence of plasmid-mediated fosfomycin resistance (fos genes) among Escherichia coli isolates, PortugalSemantic proximity Read ↗

Fosfomycin susceptibility among multidrug-resistant, extended-spectrum beta-lactamase-producing, carbapenem-resistant uropathogensSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.